About this item:

446 Views | 613 Downloads

Author Notes:

E-mail: dweinshenker@genetics.emory.edu

Conceived and designed the experiments: DW MG PMI.

Performed the experiments: MG LCL.

Analyzed the data: MG DW.

Contributed reagents/materials/analysis tools: DW PMI.

Wrote the paper: MG DW.

We thank Dainippon-Sumitomo Pharmaceuticals Inc. (Osaka, Japan) for providing the DOPS needed to maintain our Dbh mouse colony, Synosia Therapeutics for providing the nepicastat, and C. Strauss for helpful editing of the manuscript.

MGC, LCL, and PMI declare no conflict of interest.

DW is co-inventor on a patent concerning the use of selective DBH inhibitors for the treatment of cocaine dependence (US-2010-015748-A1; “Methods and Compositions for Treatment of Drug Addiction”).

This patent does not alter the authors’ adherence to all the PLOS ONE policies on sharing data and materials, has not been licensed, and DW has received no compensation under its auspices.

Subjects:

Research Funding:

This work was supported by the National Institute of Drug Abuse (DA017963 and DA027535 to DW, DA25040 and DA015040 to MGC) and the National Eye Institute (EY004864 and P30 EY06360 to PMI).

Keywords:

  • Science & Technology
  • Multidisciplinary Sciences
  • Science & Technology - Other Topics
  • MULTIDISCIPLINARY SCIENCES
  • PLACEBO-CONTROLLED TRIAL
  • INDUCED REINSTATEMENT
  • DISULFIRAM TREATMENT
  • LOCOMOTOR-ACTIVITY
  • ALCOHOL DEPENDENCE
  • PREFRONTAL CORTEX
  • DRUG-METABOLISM
  • NOREPINEPHRINE
  • ADDICTION
  • SEEKING

Chronic Inhibition of Dopamine beta-Hydroxylase Facilitates Behavioral Responses to Cocaine in Mice

Tools:

Journal Title:

PLoS ONE

Volume:

Volume 7, Number 11

Publisher:

, Pages e50583-e50583

Type of Work:

Article | Final Publisher PDF

Abstract:

The anti-alcoholism medication, disulfiram (Antabuse), decreases cocaine use in humans regardless of concurrent alcohol consumption and facilitates cocaine sensitization in rats, but the functional targets are unknown. Disulfiram inhibits dopamine β-hydroxylase (DBH), the enzyme that converts dopamine (DA) to norepinephrine (NE) in noradrenergic neurons. The goal of this study was to test the effects of chronic genetic or pharmacological DBH inhibition on behavioral responses to cocaine using DBH knockout (Dbh -/-) mice, disulfiram, and the selective DBH inhibitor, nepicastat. Locomotor activity was measured in control (Dbh +/-) and Dbh -/- mice during a 5 day regimen of saline+saline, disulfiram+saline, nepicastat+saline, saline+cocaine, disulfiram+cocaine, or nepicastat+cocaine. After a 10 day withdrawal period, all groups were administered cocaine, and locomotor activity and stereotypy were measured. Drug-naïve Dbh -/- mice were hypersensitive to cocaine-induced locomotion and resembled cocaine-sensitized Dbh +/- mice. Chronic disulfiram administration facilitated cocaine-induced locomotion in some mice and induced stereotypy in others during the development of sensitization, while cocaine-induced stereotypy was evident in all nepicastat-treated mice. Cocaine-induced stereotypy was profoundly increased in the disulfiram+cocaine, nepicastat+cocaine, and nepicastat+saline groups upon cocaine challenge after withdrawal in Dbh +/- mice. Disulfiram or nepicastat treatment had no effect on behavioral responses to cocaine in Dbh -/- mice. These results demonstrate that chronic DBH inhibition facilitates behavioral responses to cocaine, although different methods of inhibition (genetic vs. non-selective inhibitor vs. selective inhibitor) enhance qualitatively different cocaine-induced behaviors.

Copyright information:

© 2012 Gaval-Cruz et al.

This is an Open Access work distributed under the terms of the Creative Commons Attribution 4.0 International License (https://creativecommons.org/licenses/by/4.0/).
Export to EndNote